| Silpa Mundru, | |
|
13053 Starling Ct, Fairfax, VA 22033-3739 | |
| (571) 230-2782 | |
| (800) 985-9749 |
| Full Name | Silpa Mundru |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 13053 Starling Ct, Fairfax, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679979876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 2305204956 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Silpa Mundru, 13053 Starling Ct, Fairfax, VA 22033-3739 Ph: (571) 230-2782 | Silpa Mundru, 13053 Starling Ct, Fairfax, VA 22033-3739 Ph: (571) 230-2782 |
News Archive
New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader AstraZeneca in what the company believes is a world-first commercial arrangement combining digital health technology with blockbuster inhaler medications to improve health outcomes for patients with respiratory conditions.
An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.
Cornerstone Pharmaceuticals, Inc., a clinical stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a Phase I clinical trial assessing the safety and efficacy of escalating doses of CPI-613, in combination with bendamustine and rituximab, in patients with relapsed or refractory B-cell Non-Hodgkin lymphoma (NHL).
Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma (malignancy involving lymphatic tissue) of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma, according to a study in the May 9 issue of JAMA.
› Verified 5 days ago
Dr. Michael Sung Chung, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2826 Old Lee Hwy, Suite 200, Fairfax, VA 22031 Phone: 703-206-0026 Fax: 703-206-0029 | |
Tochi Nworu, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3650 Joseph Siewick Dr Ste 300, Fairfax, VA 22033 Phone: 703-393-1667 | |
Dr. Rodney B Dade, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd Ste 410, Fairfax, VA 22031 Phone: 703-738-4331 | |
Beverly A Whittenberg, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd Ste 410, Fairfax, VA 22031 Phone: 703-738-4331 Fax: 703-642-1876 | |
Ms. Kelly Marie Cardillo, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9229 Arlington Blvd, Fairfax, VA 22031 Phone: 703-277-6611 Fax: 703-383-0206 | |
Dr. Robert Harrison Wagner, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd Ste 410, Fairfax, VA 22031 Phone: 703-738-4331 Fax: 703-642-1876 |